Status:
COMPLETED
CoYoT1 to California
Lead Sponsor:
Children's Hospital Los Angeles
Collaborating Sponsors:
University of Southern California
Rutgers University
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
16-25 years
Phase:
NA
Brief Summary
CoYoT1 to California (CTC) was initiated to develop a patient-centered, home telehealth care model for young adults (YA) ages 16-25 with T1D. It is a 2x2 factorial design, 15-month intervention. Eight...
Detailed Description
1. Standard Care - Standard (in -person) appointments * Usual medical appointments. * Opportunity to participate in available community and CHLA based educational and support events. * Compl...
Eligibility Criteria
Inclusion
- Any patient aged 16-25 years of age on their date of recruitment who has had T1D for at least 6 months.
- Receiving or pending care at CHLA
- Has California Children's Services (CCS), self-pay, and/or private insurance (excluding United and Healthnet insurance)
- Does not plan to transfer out of CHLA within the next year
Exclusion
- Any patient with severe behavioral or developmental disabilities
- Severe psychological diagnoses that would make group participation difficult
- Pregnancy
- Non-English speaking patients and families
- Has United or Healthnet private insurance
- Literacy or cognitive issues that preclude the use of the Internet
Key Trial Info
Start Date :
January 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT03793673
Start Date
January 20 2019
End Date
December 31 2022
Last Update
March 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital
Los Angeles, California, United States, 90027